Sustainable Antiviral Efficacy of Rejuvenated HIV-Specific Cytotoxic T Lymphocytes Generated from Induced Pluripotent Stem Cells

MLA

Shoji Miki, et al. “Sustainable Antiviral Efficacy of Rejuvenated HIV-Specific Cytotoxic T Lymphocytes Generated from Induced Pluripotent Stem Cells.” Journal of Virology, vol. 96, Mar. 2022. EBSCOhost, https://doi.org/10.1128/jvi.02217-21.

APA

Shoji Miki, Yohei Kawai, Kaori Nakayama-Hosoya, Ryutaro Iwabuchi, Kazutaka Terahara, Yasuko Tsunetsugu-Yokota, Michiko Koga, Tetsuro Matano, Shin Kaneko, & Ai Kawana-Tachikawa. (2022). Sustainable Antiviral Efficacy of Rejuvenated HIV-Specific Cytotoxic T Lymphocytes Generated from Induced Pluripotent Stem Cells. Journal of Virology, 96. https://doi.org/10.1128/jvi.02217-21

Chicago

Shoji Miki, Yohei Kawai, Kaori Nakayama-Hosoya, Ryutaro Iwabuchi, Kazutaka Terahara, Yasuko Tsunetsugu-Yokota, Michiko Koga, Tetsuro Matano, Shin Kaneko, and Ai Kawana-Tachikawa. 2022. “Sustainable Antiviral Efficacy of Rejuvenated HIV-Specific Cytotoxic T Lymphocytes Generated from Induced Pluripotent Stem Cells.” Journal of Virology 96 (March). doi:10.1128/jvi.02217-21.